Yahoo Web Search

Search results

    • Q1 2024 Nektar Therapeutics Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 5 days ago

      We believe REZPEG has the potential to be a significant advancement in the treatment of atopic dermatitis. The new and corrected data from the Phase 1b study we reported at the EADV conference ...